Abstract:The oral microbiome is a community of symbiotic, commensal and opportunistic microorganisms, usually present in the form of biofilm, that plays a critical role in maintaining the homeostasis and protective function of the oral cavity. Recently, the study of the human oral microbiome to develop new diagnostic and therapeutic approaches has become a promising new area of the research in the field of personalized medicine. The aim of this review was to generalise and analyse the accumulated data on the relationship between the oral microbiome characteristics and the course of systemic diseases. Material and methods. Literature searches were performed using RSCI, PubMed, Google Scholar, and included original research data published mainly in the last 5 years. Results. The review summarized data on the role of the oral microbiome in the development of a number of systemic diseases, including alimentary diseases. The importance of the major exogenous and endogenous factors that lead to changes in the oral microbiome, including diet, macro- and micronutrient composition of foods, was highlighted. Data were provided on the main types of microorganisms associated with the development and c ourse of a number of somatic diseases, represented mainly by obligate anaerobic periodontal pathogens (Tannerella forsythia, Treponema denticola, Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans). The role of the systemic inflammatory response as the main pathogenetic factor of oral dysbiosis has been described. The benefits of periodontal therapy in metabolic disorders such as diabetes mellitus, obesity, and dyslipidemia have been discussed. Promising approaches to correct oral dysbiosis have been presented. Conclusion. The knowledge of the relationships between the oral microbiome composition, the development and characteristics of the course of somatic disease can contribute to the development of new technologies for its prevention and treatment. The change in the structure of the oral microbiome observed in systemic diseases is usually accompanied by a decrease in bacterial diversity and an increase in the number of pathogenic bacteria. Lifestyle modification, dietary therapy, smoking cessation, rational use of antibacterial drugs and treatment of periodontitis play an important role in normalising the structure of the oral microbiome.

Ectopic colonization by oral bacteria as an emerging theme in health and disease

Oral Microbiota: A Major Player in the Diagnosis of Systemic Diseases

The oral-gut microbiome axis in health and disease

The Bacterial Connection between the Oral Cavity and the Gut Diseases

The Oral Microbiota: Community Composition, Influencing Factors, Pathogenesis, and Interventions

[The oral microbiome in the context of systemic disease]

The oral microbiome in the pathophysiology of cardiovascular disease

The oral microbiome: Role of key organisms and complex networks in oral health and disease

Anaerobes in specific infectious and noninfectious diseases: new developments

The Oral Host-Microbial Interactome: An Ecological Chronometer of Health?

Progress in Oral Microbiome Related to Oral and Systemic Diseases: An Update

Unraveling the Oral-Gut axis: Interconnection between Periodontitis and IBD, Current Challenges, and Future Perspective

The interplay between oral microbiota, gut microbiota and systematic diseases

[Oral Microbiome and Systemic Diseases].

The involvement of oral bacteria in inflammatory bowel disease

Molecular commensalism: how oral corynebacteria and their extracellular membrane vesicles shape microbiome interactions

Oral Pathogen in the Pathogenesis of Colorectal Cancer.

New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease

Oral microbiota in human systematic diseases

Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer

Cross interaction between bacterial and fungal microbiota and their relevance to human health and disease: mechanistic pathways and prospective therapy